Related Experiment Video
Updated: Jan 9, 2026
10:09
Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment
Published on: June 2, 2020
7.2K
Extracellular vesicles and mitochondria in central nervous system diseases
Ji Hyun Park1, Dong Bin Back1, Gen Hamanaka1
1Neuroprotection Research Laboratories, Departments of Radiology and Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA.
Summary
Extracellular vesicles (EVs) show therapeutic potential for central nervous system (CNS) diseases. Mitochondria-containing EVs (mitoEVs) may also serve as biomarkers for CNS injury and recovery.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Extracellular vesicles (EVs) are key intercellular signals in the central nervous system (CNS).
- EVs regulate critical CNS functions including immune responses, aging, and tissue repair.
- Mitochondria-containing EVs (mitoEVs) represent a newly identified subset with potential roles in CNS pathophysiology.
Purpose of the Study:
- To review the critical roles of EVs in CNS injury and disease.
- To highlight the therapeutic potential of EVs in treating CNS-related disorders.
- To discuss mitoEVs as potential biomarkers for CNS injury and recovery.
Main Methods:
- Literature review of cellular, animal, and human studies.
- Analysis of current findings on EV function in the CNS.
- Synthesis of data on therapeutic applications and biomarker potential.
Main Results:
- EVs play significant roles in CNS immune responses, aging, angiogenesis, and repair.
- EVs are promising therapeutic targets for various CNS diseases.
- MitoEVs suggest a novel signaling mechanism and potential diagnostic utility in CNS conditions.
Conclusions:
- EVs, including mitoEVs, are crucial non-cell-autonomous signals in the CNS.
- EVs hold substantial therapeutic promise for CNS injury and disease.
- Further research into EVs and mitoEVs can advance CNS treatment and diagnostics.
Related Concept Videos
01:36Overview of Exosomes
3.5K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.5K
01:38Intralumenal Vesicles and Multivesicular Bodies
4.6K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
4.6K
01:26Fusion of Secretory Vesicles with the Plasma Membrane
16.5K
Proteins and neurotransmitters in secretory vesicles can be released from a cell upon vesicle docking, priming, and fusion with the plasma membrane. Vesicles are docked and primed in preparation for the quick exocytosis of their contents in response to a stimulus. The fusion process is mainly carried out by a SNAP Receptor or SNARE complex, consisting of synaptobrevin, syntaxin-1, and SNAP-25.
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
16.5K
01:33Overview of Secretory Vesicles
9.3K
Secretory vesicles, also known as dense core vesicles (DCVs), are membrane-bound vesicles that transport secretory proteins, such as hormones or neurotransmitters. Regulated secretory vesicles transport proteins from the trans-Golgi network to the exterior of the cell. Proteins present in regulated secretory vesicles are required to be rapidly exocytosed in large amounts upon a specific stimulus.
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
9.3K
01:22Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
01:37Eukaryotic Compartmentalization
17.4K
One of the distinguishing features of eukaryotic cells is that they contain membrane-bound organelles, such as the nucleus and mitochondria, that carry out specialized functions. Since biological membranes are only selectively permeable to solutes, they help create a compartment with controlled conditions inside an organelle. These microenvironments are tailored to the organelle's specific functions and help isolate them from the surrounding cytosol.
For example, lysosomes in the animal...
For example, lysosomes in the animal...
17.4K